Tag: Sevuparin

Sickle cell disease drug developer Modus Therapeutics raises $16m in new funding

pharmanewsdaily- July 15, 2018

Modus Therapeutics, a Swedish biotech company focused on developing sickle cell disease drugs, has raised SEK 140 million ($15.76 million) in a funding round led ... Read More